SCHEMBL4074886

SCHEMBL4074886

Clc1ccc(N2CC[CH]CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.59
HTR3B O95264 1/20 0.59
ADRB1 P08588 1/20 0.59
HTR3A P46098 1/20 0.59
HTR3D Q70Z44 1/20 0.59
HTR3C Q8WXA8 1/20 0.59
SIGMAR1 Q99720 1/20 0.59
CHIA Q9BZP6 1/20 0.50
LTA4H P09960 2/20 0.48
DRD4 P21917 1/20 0.48
AKR1C3 P42330 4/20 0.47
ALDH1A1 P00352 4/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 3/20 0.46
KDM4E B2RXH2 3/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068045 0.86 HTR3E (0.50) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL870704 0.85 HTR3E (0.70) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL29998630 0.85 HTR3E (0.70) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL1822749 0.80 HTR3E (0.64) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL24103508 0.80 SIGMAR1 (0.64) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL708444 0.78 ALDH1A1 (0.63) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL708442 0.78 ALDH1A1 (0.63) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL2346745 0.76 MAPT (0.53) DRD4ALDH1A1LMNAMAPTKDM4E
SCHEMBL21690 0.76 MAPT (0.66) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL4064416 0.76 ADRB1 (0.59) ADRB1AKR1C3ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737361-A1 INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE Centaurus Therapeutics (US) 2020-11-18 EP disclosed
EP-3515914-A1 NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a]PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES BeiGene, Ltd. (KY) 2019-07-31 EP disclosed
WO-2018054365-A1 NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES BEIGENE, LTD. (KY) 2018-03-29 WO disclosed
CN-105555783-A Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core NOVARTIS AG 2016-05-04 CN disclosed
CN-104520292-A Sulfonyl piperidine derivatives and use for treating prokineticin mediated diseases TAKEDA PHARMACEUTICAL 2015-04-15 CN disclosed
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 US disclosed
CN-1538956-A Spiro compounds ������ҩ��ʽ���� 2004-10-20 CN disclosed